HK1213819A1 - 用於防止或減少腦和全身再灌注損傷的保護液 - Google Patents

用於防止或減少腦和全身再灌注損傷的保護液

Info

Publication number
HK1213819A1
HK1213819A1 HK16101969.7A HK16101969A HK1213819A1 HK 1213819 A1 HK1213819 A1 HK 1213819A1 HK 16101969 A HK16101969 A HK 16101969A HK 1213819 A1 HK1213819 A1 HK 1213819A1
Authority
HK
Hong Kong
Prior art keywords
brain
preventing
whole body
reperfusion injury
protective solution
Prior art date
Application number
HK16101969.7A
Other languages
English (en)
Inventor
Christoph Benk
Friedhelm Beyersdorf
Georg Trummer
Original Assignee
Resuscitec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resuscitec Gmbh filed Critical Resuscitec Gmbh
Publication of HK1213819A1 publication Critical patent/HK1213819A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16101969.7A 2013-07-05 2016-02-23 用於防止或減少腦和全身再灌注損傷的保護液 HK1213819A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13175243.8A EP2821081A1 (en) 2013-07-05 2013-07-05 Protective solution for preventing or reducing reperfusion injury of the brain and the whole body
PCT/EP2014/063905 WO2015000871A1 (en) 2013-07-05 2014-07-01 Protective solution for preventing or reducing reperfusion injury of the brain and the whole body

Publications (1)

Publication Number Publication Date
HK1213819A1 true HK1213819A1 (zh) 2016-07-15

Family

ID=48782915

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101969.7A HK1213819A1 (zh) 2013-07-05 2016-02-23 用於防止或減少腦和全身再灌注損傷的保護液

Country Status (10)

Country Link
US (2) US10695407B2 (zh)
EP (2) EP2821081A1 (zh)
JP (1) JP6389518B2 (zh)
KR (1) KR102244530B1 (zh)
CN (1) CN105246502A (zh)
ES (1) ES2640383T3 (zh)
HK (1) HK1213819A1 (zh)
PL (1) PL3016675T3 (zh)
RU (1) RU2672558C2 (zh)
WO (1) WO2015000871A1 (zh)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552267A (en) * 1992-04-03 1996-09-03 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US7288551B1 (en) * 2000-09-19 2007-10-30 Charlotte-Mecklenburg Hospital Authority Solution for the preservation of hearts
AU2002214443B2 (en) * 2000-11-03 2005-12-15 Vitrolife Ab Evaluation and preservation solution
DE10222561B4 (de) 2002-05-17 2009-12-10 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
GB0403509D0 (en) * 2004-02-17 2004-03-24 Neuro Targets Ltd Galanin receptors and brain injury
GB0612877D0 (en) * 2006-06-29 2006-08-09 Univ Edinburgh Organ preservation solution
CN101721688B (zh) * 2008-10-13 2012-07-04 首都医科大学宣武医院 基于神经介入微导管技术的脑保护灌注液及其制备方法
CN102482338B (zh) 2009-07-10 2016-09-28 斯路姆基因公司 纤溶酶原和纤溶酶的变体
US8288084B2 (en) * 2009-07-12 2012-10-16 Revive Organtech, Inc. Composition and method for flushing and cold/cryo preserving organs, tissues, and cells
DE102009045589A1 (de) 2009-10-12 2011-04-14 Universitätsklinikum Freiburg Vorrichtung zur Behandlung eines Individuums mit Herzminderleistung, Herzstillstand oder Schlaganfall
RU202597U1 (ru) * 2020-08-11 2021-02-26 Общество с ограниченной ответственностью "Информационные технологии" (ООО "ИнфоТех") Устройство магнитной цепи для обнаружения и последующего снижения напряженности магнитного поля в зазоре изолирующего стыка

Also Published As

Publication number Publication date
RU2016103656A3 (zh) 2018-05-29
JP6389518B2 (ja) 2018-09-12
US20160367643A1 (en) 2016-12-22
BR112015029121A2 (pt) 2017-07-25
US10695407B2 (en) 2020-06-30
KR102244530B1 (ko) 2021-04-27
JP2016523876A (ja) 2016-08-12
EP2821081A1 (en) 2015-01-07
WO2015000871A1 (en) 2015-01-08
EP3016675B1 (en) 2017-08-16
KR20160030191A (ko) 2016-03-16
CN105246502A (zh) 2016-01-13
US11185574B2 (en) 2021-11-30
EP3016675A1 (en) 2016-05-11
RU2672558C2 (ru) 2018-11-16
PL3016675T3 (pl) 2017-12-29
US20200276277A1 (en) 2020-09-03
RU2016103656A (ru) 2017-08-10
ES2640383T3 (es) 2017-11-02

Similar Documents

Publication Publication Date Title
IL264541B (en) The history of sulfamoylpyrrolamide and their use as drugs to treat jaundice b
HRP20181863T1 (hr) Derivati sulfamoiltiofenamida i njihova uporaba kao lijekova za liječenje hepatitisa b
HRP20170945T1 (hr) Sulfamoil-arilamidi i njihova uporaba kao lijekova za liječenje hepatitisa b
HK1222530A1 (zh) 用於皮膚處理的微閉合及相關方法
HK1217330A1 (zh) -苯基-氨甲酰衍生物及其作爲藥物用於治療乙型肝炎的用途
HK1209424A1 (zh) 用於治療再灌注損傷的氧雜二環庚烷和氧雜二環庚烯
EP2986113A4 (en) Compositions and methods for the treatment of brain injury
HK1213819A1 (zh) 用於防止或減少腦和全身再灌注損傷的保護液
EP2981324A4 (en) METHODS AND ARTICLES MANUFACTURED FOR THE TREATMENT OF SKIN
AP2015008814A0 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b